Hims & Hers Health Inc’s recently made public that its Officer Chi Michael acquired Company’s shares for reported $52425.0 on Oct 10 ’25. In the deal valued at $58.25 per share,900 shares were bought.
Then, Okupe Oluyemi sold 11,595 shares, generating $669,232 in total proceeds. Upon selling the shares at $57.72, the Chief Financial Officer now owns 70,232 shares.
Before that, Chi Michael sold 250 shares. Hims & Hers Health Inc shares valued at $14,000 were divested by the Chief Commercial Officer at a price of $56.00 per share. As a result of the transaction, Chi Michael now holds 291,439 shares, worth roughly $15.95 million.
Needham downgraded its Hims & Hers Health Inc [HIMS] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in early June has reiterated a ‘”a Buy”‘ rating for it. TD Cowen also remained covering HIMS and has decreased its forecast on April 29, 2025 with a “Hold” recommendation from previously “Buy” rating. Morgan Stanley revised its rating on February 18, 2025. It rated HIMS as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock jump 1.45% to $54.73. Over the last five days, the stock has lost -0.05%. Hims & Hers Health Inc shares have risen nearly 192.21% since the year began. Nevertheless, the stocks have risen 126.34% over the past one year.
How much short interest is there in Hims & Hers Health Inc?
A steep rise in short interest was recorded in Hims & Hers Health Inc stocks on 2025-09-30, dropping by -3.62 million shares to a total of 71.01 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 74.64 million shares. There was a decline of -5.1%, which implies that there is a negative sentiment for the stock.
